v3.25.1
SCHEDULE OF COMPANY AND SUBSIDIARIES (Details)
 12 Months Ended
Sep. 30, 2024
Maius Pharmaceutical Limited [Member]  
Percentage of Direct or Indirect Economic Ownership 100.00%
Principal Activity Investment holding
Maius Pharmaceutical (Hong Kong) Co., Ltd [Member]  
Percentage of Direct or Indirect Economic Ownership 100.00%
Principal Activity Investment holding
ShangHai Maius Pharmaceutical Co., Ltd [Member]  
Percentage of Direct or Indirect Economic Ownership 100.00%
Principal Activity Provide R&D of drugs
Maius Pharma Technology Limited [Member]  
Percentage of Direct or Indirect Economic Ownership 100.00%
Principal Activity Investment holding
Maius Pharma Technology (HK) Co., Limited [Member]  
Percentage of Direct or Indirect Economic Ownership 100.00%
Principal Activity Investment holding
Maius Pharmaceutical (MACAO) Co., Limited [Member]  
Percentage of Direct or Indirect Economic Ownership 100.00%
Principal Activity Investment holding
Maius Pharmaceutical Limited [Member]  
Date of Incorporation or Acquisition August 13, 2018
Place of incorporation British Virgin Islands
Maius Pharmaceutical (Hong Kong) Co., Ltd [Member]  
Date of Incorporation or Acquisition August 29, 2018
Place of incorporation Hong Kong
ShangHai Maius Pharmaceutical Co., Ltd [Member]  
Date of Incorporation or Acquisition July 14, 2015
Place of incorporation PRC
Maius Pharma Technology Limited [Member]  
Date of Incorporation or Acquisition March 26, 2024
Place of incorporation British Virgin Islands
Maius Pharma Technology (HK) Co., Limited [Member]  
Date of Incorporation or Acquisition April 12, 2024
Place of incorporation Hong Kong
Maius Pharmaceutical (MACAO) Co., Limited [Member]  
Date of Incorporation or Acquisition June 14, 2024
Place of incorporation Macao